TOFA: Can it burn fat without making you eat less?

A new study suggests that a chemical compound called TOFA could potentially reduce body fat in mice without making them consume less food. GLP-1 medicines, such as Ozempic and Mounjaro, have already been effective in treating obesity, diabetes, and metabolic conditions primarily by controlling appetite and satiety. Researchers have been seeking alternative methods to lose weight, and TOFA may offer a novel way to help the body expend more energy without reducing food intake.

The compound, first studied nearly 50 years ago, appears to suppress fatty acid synthesis while activating pathways involved in burning fat and expending energy. To test its potential, researchers examined various doses and treatment schedules in over 20 experiments involving mouse models of obesity, diabetes, and fatty liver disease.

They found that mice receiving TOFA lost weight from fat without experiencing significant muscle mass loss. Moreover, the treated cells burned up to 18% more energy without any change in physical activity or body temperature. Importantly, TOFA did not raise triglyceride levels. However, it is essential to note that TOFA has not been tested in humans, so its effects on people remain unknown.

Appropriate dosages and potential side effects have yet to be determined. While these results are promising, experts emphasize that pre-clinical success in animal models does not guarantee clinical efficacy or safety. Therefore, TOFA remains an experimental laboratory compound and is not an approved obesity treatment. Researchers caution that individuals seeking weight loss should not rely on TOFA or similar research chemicals, as proper human trials are necessary to establish safety and effectiveness. Instead, they advise adhering to evidence-based methods for managing obesity.